Literature DB >> 12835292

Pathogenesis of systemic lupus erythematosus.

C C Mok1, C S Lau.   

Abstract

The exact patho-aetiology of systemic lupus erythematosus (SLE) remains elusive. An extremely complicated and multifactorial interaction among various genetic and environmental factors is probably involved. Multiple genes contribute to disease susceptibility. The interaction of sex, hormonal milieu, and the hypothalamo-pituitary-adrenal axis modifies this susceptibility and the clinical expression of the disease. Defective immune regulatory mechanisms, such as the clearance of apoptotic cells and immune complexes, are important contributors to the development of SLE. The loss of immune tolerance, increased antigenic load, excess T cell help, defective B cell suppression, and the shifting of T helper 1 (Th1) to Th2 immune responses leads to B cell hyperactivity and the production of pathogenic autoantibodies. Finally, certain environmental factors are probably required to trigger the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835292      PMCID: PMC1769989          DOI: 10.1136/jcp.56.7.481

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  140 in total

1.  Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  N Kanda; T Tsuchida; K Tamaki
Journal:  Arthritis Rheum       Date:  1997-09

2.  Use of exogenous estrogens in systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; R W Wong
Journal:  Semin Arthritis Rheum       Date:  2001-06       Impact factor: 5.532

3.  Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells.

Authors:  Y Shoshan; I Shapira; E Toubi; I Frolkis; M Yaron; D Mevorach
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.

Authors:  H R Yun; H K Koh; S S Kim; W T Chung; D W Kim; K P Hong; G G Song; H K Chang; J Y Choe; S C Bae; J E Salmon; D H Yoo; T Y Kim; S Y Kim
Journal:  Lupus       Date:  2001       Impact factor: 2.911

5.  Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes.

Authors:  T F Liu; B M Jones
Journal:  Cytokine       Date:  1998-02       Impact factor: 3.861

6.  Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo.

Authors:  D Vlahakos; M H Foster; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  J Am Soc Nephrol       Date:  1992-02       Impact factor: 10.121

Review 7.  Retroviruses and systemic lupus erythematosus.

Authors:  M Herrmann; M Hagenhofer; J R Kalden
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

8.  Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.

Authors:  R W McMurray; D Weidensaul; S H Allen; S E Walker
Journal:  J Rheumatol       Date:  1995-11       Impact factor: 4.666

9.  Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood.

Authors:  E Hagiwara; M F Gourley; S Lee; D K Klinman
Journal:  Arthritis Rheum       Date:  1996-03

10.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; O M Zoller; M Hagenhofer; B B Ponner; J R Kalden
Journal:  Arthritis Rheum       Date:  1998-07
View more
  204 in total

1.  Differential roles of estrogen receptors α and β in control of B-cell maturation and selection.

Authors:  Latia Hill; Venkatesh Jeganathan; Prameladevi Chinnasamy; Christine Grimaldi; Betty Diamond
Journal:  Mol Med       Date:  2010-11-22       Impact factor: 6.354

2.  HDAC expression and activity is upregulated in diseased lupus-prone mice.

Authors:  Nicole L Regna; Miranda D Vieson; Alexander M Gojmerac; Xin M Luo; David L Caudell; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2015-10-21       Impact factor: 4.932

3.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.

Authors:  Katalin Kis-Toth; Denis Comte; Maria P Karampetsou; Vasileios C Kyttaris; Lakshmi Kannan; Cox Terhorst; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

4.  Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Young Hee Rho; Joseph Solus; Paolo Raggi; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

5.  Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.

Authors:  María J Molina; Angel M Mayor; Alejandro E Franco; Carlos A Morell; Miguel A López; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2007-08       Impact factor: 3.517

6.  Systemic Lupus Erythematosus Associated Pitfalls on 18F-FDG PET/CT: Reactive Follicular Hyperplasia, Kikuchi-Fujimoto Disease, Inflammation and Lymphoid Hyperplasia of the Spleen Mimicking Lymphoma.

Authors:  William Makis; Anthony Ciarallo; Milene Gonzalez-Verdecia; Stephan Probst
Journal:  Nucl Med Mol Imaging       Date:  2017-01-29

Review 7.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

8.  Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Yu-Yan Cheng; Yu-Jun Sheng; Yan Chang; Yan Lin; Zheng-Wei Zhu; Lei-Lei Wen; Chao Yang; Lu Liu; Lu-Lu Yang; Fu-Sheng Zhou; Xiao-Dong Zheng; Xian-Yong Yin; Sheng-Quan Zhang; Yong Cui; Sen Yang; Xue-Jun Zhang
Journal:  Clin Rheumatol       Date:  2015-04-25       Impact factor: 2.980

9.  Contemporary treatment of systemic lupus erythematosus: an update for clinicians.

Authors:  Maame B Amissah-Arthur; Caroline Gordon
Journal:  Ther Adv Chronic Dis       Date:  2010-07       Impact factor: 5.091

10.  Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice.

Authors:  I Molano; J Mathenia; P Ruiz; G S Gilkeson; X K Zhang
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.